RETRACTED: ANRIL acts as onco-lncRNA by regulation of microRNA-24/c-Myc, MEK/ERK and Wnt/β-catenin pathway in retinoblastoma.
Cell Movement
/ genetics
Cell Proliferation
/ genetics
Cell Survival
/ genetics
Child, Preschool
Female
Gene Expression Regulation, Neoplastic
/ genetics
Humans
Infant
MAP Kinase Signaling System
/ genetics
Male
MicroRNAs
/ genetics
Neoplasm Invasiveness
Proto-Oncogene Proteins c-myc
/ genetics
RNA, Long Noncoding
/ genetics
Retinoblastoma
/ genetics
Wnt Signaling Pathway
/ genetics
Antisense non-coding RNA in the INK4 locus
MEK/ERK pathway
MicroRNA-24
Retinoblastoma
Wnt/β-catenin pathway
c-Myc
Journal
International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578
Informations de publication
Date de publication:
01 05 2019
01 05 2019
Historique:
received:
30
08
2018
revised:
16
01
2019
accepted:
28
01
2019
pubmed:
1
2
2019
medline:
25
6
2019
entrez:
1
2
2019
Statut:
ppublish
Résumé
This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).
This article has been retracted at the request of the Authors. Current research findings in the authors' laboratory are in conflict with previous experimental results published in this paper. It was found that the data reported in figures 4 and 5 were not able to be replicated and so therefore the authors have decided that it is best for the scientific record to retract this paper.
All the authors agree with the retraction. The authors apologise for any confusion this paper might have caused readers.
Identifiants
pubmed: 30703428
pii: S0141-8130(18)34567-7
doi: 10.1016/j.ijbiomac.2019.01.157
pii:
doi:
Substances chimiques
CDKN2B antisense RNA, human
0
MIRN24 microRNA, human
0
MYC protein, human
0
MicroRNAs
0
Proto-Oncogene Proteins c-myc
0
RNA, Long Noncoding
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
583-592Informations de copyright
Copyright © 2019. Published by Elsevier B.V.